Wearable Injectors Industry Research Report, Growth Trends and Competitive Analysis

The global wearable injectors market is predicted to register significant growth in the coming years. This is attributed to the increasing demand for advanced drug delivery, rising geriatric population, and surging prevalence of chronic diseases. A device which is utilized for delivering large volume of drugs over an extended period of time is referred to as a wearable injector. The device delivers large subcutaneous doses of drugs to patients even when the patient is ambulatory and is able to carry out normal daily life activities during the drug delivery.

Receive  Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/wearable-injectors-market/report-sample

In terms of end user, the wearable injectors market is categorized into lab & diagnostics, home care, hospital, and others (which include small clinics and healthcare settings). Out of these, the home care category dominated the market in the past and is expected to account for the major share of the market in the near future as well due to the growing demand for self-injection system. On the basis of technology, the market is classified into mechanical injector, electronic injector, and others (which include hydrogel and hydraulic injector).

The surging geriatric population is among the major driving factors of the wearable injectors market. According to the United Nations Department of Economic and Social Affairs report on the global aging population, the number of people aged 60 years or above is expected to grow by 56%, i.e., from 901 million in 2015 to 1.4 billion by 2030. Moreover, the elderly people are more susceptible to chronic diseases as they have low immunity levels. Attributed to these factors, the demand for wearable injectors is growing with the rising aging population.

Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=wearable-injectors-market

Another key driving factor of the wearable injectors market is the increasing requirement for innovative drug delivery. Infusion therapy costs around $35 billion in the specialty drug market, according to Unilife Corporation. The utilization of advanced drug delivery devices, including wearable injectors at home, decreases the overall healthcare cost, as the patients can take the drugs themselves with minimal or no training. Furthermore, these drug delivery devices are being preferred by different healthcare setups, including labs & diagnostics and clinics, as they are cheaper than other controlled drug delivery devices. 

Hence, the market is being driven by the increasing geriatric population and rising need for advanced drug delivery